CDE releases 3 technical guidelines for anti-coronavirus drugs

On December 7, CDE issued the "Technical Guidelines for Non-clinical Pharmacodynamic Research and Evaluation of Anti-coronavirus Chemical Drugs (Trial)" and "Technical Guidelines for Non-clinical Pharmacodynamic Research and Evaluation of Anti-coronavirus Pneumonia Drugs (Trial)" The "Technical Guidelines for Non-clinical Research on Novel Coronavirus Neutralizing Antibody Drugs (Trial)" will come into effect on the date of issuance

The original text is as follows:

The Center for Drug Evaluation of the National Food and Drug Administration on the release of "Technical Guidelines for Non-clinical Pharmacodynamic Research and Evaluation of Anti-coronavirus Chemical Drugs (Trial)" and "Technical Guidelines for Non-clinical Pharmacodynamic Research and Evaluation of Anti-coronavirus Pneumonia Inflammatory Drugs (Trial) ) "Notice of "Technical Guidelines for Non-clinical Research of Novel Coronavirus Neutralizing Antibody Drugs (Trial)" (No.

In view of the occurrence and development of the domestic and international new crown epidemic and the needs of clinical treatment, anti-new crown virus chemical drugs, treatment of new crown virus pneumonia inflammation drugs and new crown virus neutralizing antibody drugs have become the focus of anti-epidemic drug development and review

Appendix:

1.

2.

3.